Seel, a couple of posters more in tune than I have
Post# of 72440
What is your current opinion as to the likelihood that Kevetrin will make it to a pretty hefty MTD, or at least one higher than the 100-200 dosage rate where the pre clinical testing showed high efficacy?
Don't wreck my weekend and say you see no lesser risk now for Ph1 than when the trial started. LOL.